Skip to nav Skip to content
Facebook Twitter LinkedIn Email

IDSA Encouraged by President’s Prioritization of Antimicrobial Resistance  

The Infectious Diseases Society of America is heartened by the Administration’s recognition that antimicrobial resistance is a serious and urgent threat to patients and public health.

The President’s budget request includes significant increased funding to support antimicrobial research and development, stewardship, surveillance and prevention. Specifically, the inclusion of a proposal to delink antimicrobial drug revenue from volume of sales through annual contract payments for innovative antimicrobials — a proposal that aligns with the bipartisan PASTEUR Act — represents major progress that would revitalize sustainable antimicrobial R&D. 

IDSA urges Congress to realize the goals outlined in the budget by passing the PASTEUR Act and significantly increasing funding for antimicrobial resistance activities across federal agencies, including CDC, NIAID and BARDA.

Daniel P. McQuillen, MD, FIDSA – President, Infectious Diseases Society of America

About IDSA
The Infectious Diseases Society of America (IDSA) is a community of over 12,000 physicians, scientists, and public health experts who specialize in infectious diseases. Its purpose is to improve the health of individuals, communities, and society by promoting excellence in patient care, education, research, public health, and prevention relating to infectious diseases. Learn more at

This website uses cookies

We use cookies to ensure that we give you the best experience on our website. Cookies facilitate the functioning of this site including a member login and personalized experience. Cookies are also used to generate analytics to improve this site as well as enable social media functionality.